University of California Berkeley scores win in CRISPR patent rivalry

Print Friendly, PDF & Email
Image credit: Sarah Fulcher / Flickr

The University of California will soon be granted a potentially valuable patent on the revolutionary gene-editing technology known as CRISPR, according to a document filed by the U.S. patent office on [February 8].

The U.S. Patent and Trademark Office decision to grant the patent could further fuel a long-running rivalry between the university and the Broad Institute, a biological and genomic research center affiliated with the Massachusetts Institute of Technology (MIT) and Harvard University that also holds patents on CRISPR.

Patent rights to CRISPR could eventually be worth billions of dollars, because the technology could revolutionize the treatment of diseases, crop engineering and other areas.

Related article:  As the CRISPR revolution advances, here's how gene editing will actually help farmers and consumers

The patent being approved stems from an application filed by microbiologists Jennifer Doudna of the University of California at Berkeley and Emmanuelle Charpentier of the University of Vienna in 2012. …

A team at the Broad Institute led by bioengineer Feng Zhang applied for their own patent months later, but paid for a fast-track review process, which landed them the first CRISPR patent in 2014. The Broad’s patents covered CRISPR’s use in so-called eukaryotic cells, which include animal and human cells.

Read full, original post: University of California to be granted pioneering CRISPR patent

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists